{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:15:03Z","timestamp":1787062503661,"version":"build-2736575974"},"reference-count":35,"publisher":"Impact Journals, LLC","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,12]]},"DOI":"10.18632\/oncotarget.17729","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T15:09:25Z","timestamp":1494342565000},"page":"65123-65131","source":"Crossref","is-referenced-by-count":13,"title":["Anti-tumor activity of anthrax toxin variants that form a functional translocation pore by intermolecular complementation"],"prefix":"10.18632","volume":"8","author":[{"given":"Shihui","family":"Liu","sequence":"first","affiliation":[{"name":"Proteases and Tissue Remodeling Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA"},{"name":"Microbial Pathogenesis Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Ma","sequence":"additional","affiliation":[{"name":"Microbial Pathogenesis Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasem","family":"Fattah","sequence":"additional","affiliation":[{"name":"Microbial Pathogenesis Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Bugge","sequence":"additional","affiliation":[{"name":"Proteases and Tissue Remodeling Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Leppla","sequence":"additional","affiliation":[{"name":"Microbial Pathogenesis Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,5,9]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"E4079","DOI":"10.1073\/pnas.1600982113","article-title":"Solid tumor therapy by selectively targeting stromal endothelial cells","volume":"113","author":"Leppla","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nbt1091","article-title":"Intermolecular complementation achieves high-specificity tumor targeting by anthrax toxin","volume":"23","author":"Leppla","year":"2005","journal-title":"Nat Biotechnol"},{"key":"3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/14712598.3.5.843","article-title":"Anthrax toxin: structures, functions and tumour targeting","volume":"3","author":"Leppla","year":"2003","journal-title":"Expert Opin Biol Ther"},{"key":"4","doi-asserted-by":"crossref","first-page":"e20532","DOI":"10.1371\/journal.pone.0020532","article-title":"Efficient targeting of head and neck squamous cell carcinoma by systemic administration of a dual uPA and MMP-activated engineered anthrax toxin","volume":"6","author":"Bugge","year":"2011","journal-title":"PLoS One"},{"key":"5","doi-asserted-by":"crossref","first-page":"e1003","DOI":"10.1038\/cddis.2013.540","article-title":"Cytolethal distending toxin B as a cell-killing component of tumor-targeted anthrax toxin fusion proteins","volume":"5","author":"Leppla","year":"2014","journal-title":"Cell Death Dis"},{"key":"6","doi-asserted-by":"crossref","first-page":"9058","DOI":"10.1074\/jbc.M113.452110","article-title":"Engineering Anthrax Toxin Variants That Exclusively Form Octamers and Their Application to Targeting Tumors","volume":"288","author":"Leppla","year":"2013","journal-title":"J Biol Chem"},{"key":"7","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1158\/1535-7163.MCT-13-0358","article-title":"Receptor-directed chimeric toxins created by sortase-mediated protein fusion","volume":"12","author":"Collier","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"8","first-page":"440","article-title":"Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigen","volume":"7","author":"Collier","year":"2012","journal-title":"Mol Oncol"},{"key":"9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"Young","year":"2001","journal-title":"Nature"},{"key":"10","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor","volume":"100","author":"Young","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tim.2014.02.012","article-title":"Anthrax lethal and edema toxins in anthrax pathogenesis","volume":"22","author":"Leppla","year":"2014","journal-title":"Trends Microbiol"},{"key":"12","doi-asserted-by":"crossref","first-page":"9802","DOI":"10.1073\/pnas.0604000103","article-title":"A loop network within the anthrax toxin pore positions the phenylalanine clamp in an active conformation","volume":"103","author":"Collier","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.biochem.75.103004.142728","article-title":"Anthrax toxin: receptor-binding, internalization, pore formation, and translocation","volume":"76","author":"Collier","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.mam.2009.06.003","article-title":"Membrane translocation by anthrax toxin","volume":"30","author":"Collier","year":"2009","journal-title":"Mol Aspects Med"},{"key":"15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1172\/JCI17991","article-title":"lethal toxin induces TNF-\u00e1-independent hypoxia-mediated toxicity in mice","volume":"112","author":"Leppla","year":"2003","journal-title":"J Clin Invest"},{"key":"16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature12510","article-title":"Key tissue targets responsible for anthrax-toxin-induced lethality","volume":"501","author":"Leppla","year":"2013","journal-title":"Nature"},{"key":"17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-micro-091014-104523","article-title":"Anthrax Pathogenesis","volume":"69","author":"Liu","year":"2015","journal-title":"Annu Rev Microbiol"},{"key":"18","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Vande Woude GF. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor","volume":"280","author":"Paull","year":"1998","journal-title":"Science"},{"key":"19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2672.1999.00893.x","article-title":"Anthrax lethal factor cleaves the N-terminus of MAPKKS and induces tyrosine\/threonine phosphorylation of MAPKS in cultured macrophages","volume":"87","author":"Montecucco","year":"1999","journal-title":"J Appl Microbiol"},{"key":"20","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd4281","article-title":"Targeting RAS-ERK signalling in cancer: promises and challenges","volume":"13","author":"Poulikakos","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"21","doi-asserted-by":"crossref","first-page":"17976","DOI":"10.1074\/jbc.M011085200","article-title":"Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin","volume":"276","author":"Leppla","year":"2001","journal-title":"J Biol Chem"},{"key":"22","first-page":"6061","article-title":"Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin","volume":"60","author":"Leppla","year":"2000","journal-title":"Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"e3130","DOI":"10.1371\/journal.pone.0003130","article-title":"Role of N-terminal amino acids in the potency of anthrax lethal factor","volume":"3","author":"Leppla","year":"2008","journal-title":"PLoS One"},{"key":"24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pep.2011.05.016","article-title":"Astrain deleted for six proteases serves as an effective host for production of recombinant proteins","volume":"80","author":"Leppla","year":"2011","journal-title":"Protein Expr Purif"},{"key":"25","doi-asserted-by":"crossref","first-page":"15542","DOI":"10.1016\/S0021-9258(19)49569-0","article-title":"Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain ofexotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells","volume":"267","author":"Leppla","year":"1992","journal-title":"J Biol Chem"},{"key":"26","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1158\/1078-0432.CCR-11-0493","article-title":"Pentostatin plus cyclophosphamide safely and effectively prevents immunotoxin immunogenicity in murine hosts","volume":"17","author":"Fowler","year":"2011","journal-title":"Clin Cancer Res"},{"key":"27","first-page":"208ra147","article-title":"Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppression","volume":"5","author":"Pastan","year":"2013","journal-title":"Sci Transl Med"},{"key":"28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1073\/pnas.0236849100","article-title":"Potent antitumor activity of a urokinase-activated engineered anthrax toxin","volume":"100","author":"Bugge","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"29","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1073\/pnas.062160399","article-title":"Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen","volume":"99","author":"Collier","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"30","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1073\/pnas.052160199","article-title":"The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen","volume":"99","author":"Collier","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"31","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nsmb.1923","article-title":"Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers","volume":"17","author":"Krantz","year":"2010","journal-title":"Nat Struct Mol Biol"},{"key":"32","doi-asserted-by":"crossref","first-page":"16267","DOI":"10.1038\/srep16267","article-title":"An anthrax toxin variant with an improved activity in tumor targeting","volume":"5","author":"Liu","year":"2015","journal-title":"Sci Rep"},{"key":"33","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1200\/JCO.2005.04.3836","article-title":"Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia","volume":"24","author":"Weiss","year":"2006","journal-title":"J Clin Oncol"},{"key":"34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1182\/blood-2006-07-033274","article-title":"Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia","volume":"109","author":"Grever","year":"2007","journal-title":"Blood"},{"key":"35","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1074\/jbc.M210321200","article-title":"Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization","volume":"278","author":"Leppla","year":"2003","journal-title":"J Biol Chem"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17729","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T07:13:02Z","timestamp":1658992382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,9]]},"references-count":35,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2017,9,12]]}},"alternative-id":["17729","29029417"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.17729","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,9]]}}}